Drugs / fluoxetin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00768820 Background | May 2001 → Aug 2027 expected | Williams syndrome, fragile X syndrome, velocardiofacial syndrome | The Chaim Sheba Medical Center | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fluoxetin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00768820 ↗ |